Clinical Trial Update: Medium Chain Triglycerides (MCT) and Whey Protein Isolate (WPI) for Type 2 Diabetes Patients (Combine) [NA]

View source ↗

Summary

A completed clinical trial evaluated combining medium-chain triglycerides and whey protein isolate in adults with Type 2 diabetes to assess outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Medium Chain Triglycerides (Medium-chain triglycerides)
• Whey Protein Isolate (Whey protein isolate)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Type 2 Diabetes | NA | Status: COMPLETED